| |||||||||
Type Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation F?+6p Donating Investigator Klaus Rajewsky, Harvard Medical School Appearance
black
Related Genotype: a/aDescription
Mice homozygous for the Igk-Ctm1Cgn targeted mutation are viable and fertile. The number of B cells expressing l chain is increased 2-fold in heterozygotes and 7-fold in homozygotes.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Igk-C
007595 B6;129-Igk-Ctm1(IGKC)Mnz/J 005018 NOD.Cg-Tg(Igk-C/Igk-V125)1Jwt/JwtJ View Strains carrying other alleles of Igk-C (2 strains)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Igk-Ctm1Cgn/Igk-C+
involves: C57BL/6
- immune system phenotype
- increased mature B cell number (MGI Ref ID J:64287)
- 2 fold increase of lambda-chain expressing B cells
- hematopoietic system phenotype
- increased mature B cell number (MGI Ref ID J:64287)
- 2 fold increase of lambda-chain expressing B cells
Igk-Ctm1Cgn/Igk-Ctm1Cgn
involves: C57BL/6
- immune system phenotype
- abnormal B cell differentiation (MGI Ref ID J:64287)
- 50% decrease in recombination of the Jk-kappa and V-kappa gene segments in splenic B cells
- increased immature B cell number (MGI Ref ID J:64287)
- the percentage of immature B cells in bone marrow is double that of wild-type
- decreased mature B cell number (MGI Ref ID J:64287)
- 2.3 fold less B cells in the spleen
- B cells expressing kappa chain completely absent in the spleen
- the percentage of newly generated B cell in the bone marrow is half that of wild-type
- increased mature B cell number (MGI Ref ID J:64287)
- 7 fold increase of lambda-chain expressing B cells
- spleen hypoplasia (MGI Ref ID J:64287)
- 30% fewer nucleated cells found in the spleen
- hematopoietic system phenotype
- abnormal B cell differentiation (MGI Ref ID J:64287)
- 50% decrease in recombination of the Jk-kappa and V-kappa gene segments in splenic B cells
- increased immature B cell number (MGI Ref ID J:64287)
- the percentage of immature B cells in bone marrow is double that of wild-type
- decreased mature B cell number (MGI Ref ID J:64287)
- 2.3 fold less B cells in the spleen
- B cells expressing kappa chain completely absent in the spleen
- the percentage of newly generated B cell in the bone marrow is half that of wild-type
- increased mature B cell number (MGI Ref ID J:64287)
- 7 fold increase of lambda-chain expressing B cells
- spleen hypoplasia (MGI Ref ID J:64287)
- 30% fewer nucleated cells found in the spleen
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Igk-C related
Igk-Ctm1Cgn relatedImmunology and Inflammation Research
Autoimmunity
Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Immunodeficiency
| Allele Symbol | Igk-Ctm1Cgn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, University of Cologne | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | CkappaT; kappa-; | ||
| Mutation Made By | Yong-Rui Zou, University of Cologne | ||
| Strain of Origin | C57BL/6 | ||
| ES Cell Line Name | BL/6-III | ||
| ES Cell Line Strain | C57BL/6 | ||
| Gene Symbol and Name | Igk-C, immunoglobulin kappa chain, constant region | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | HCAK1; Igkc; Km; MGC111575; MGC62011; MGC72072; MGC88770; MGC88771; MGC88809; | ||
| Molecular Note | A neomycin resistance cassette replaced the exon encoding the constant region of the immunoglobulin kappa chain, its splicing signal and polyadenylation site. [MGI Ref ID J:64287] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Zou YR; Takeda S; Rajewsky K. 1993. Gene targeting in the Ig kappa locus: efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa. EMBO J 12(3):811-20. [PubMed: 8458339] [MGI Ref ID J:64287]
Igk-Ctm1Cgn relatedCasellas R; Nussenzweig A; Wuerffel R; Pelanda R; Reichlin A; Suh H; Qin XF; Besmer E; Kenter A; Rajewsky K; Nussenzweig MC. 1998. Ku80 is required for immunoglobulin isotype switching. EMBO J 17(8):2404-11. [PubMed: 9545251] [MGI Ref ID J:127088]
Mao C; Jiang L; Melo-Jorge M; Puthenveetil M; Zhang X; Carroll MC; Imanishi-Kari T. 2004. T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity 20(2):133-44. [PubMed: 14975236] [MGI Ref ID J:89757]
Pape KA; Kouskoff V; Nemazee D; Tang HL; Cyster JG; Tze LE; Hippen KL; Behrens TW; Jenkins MK. 2003. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med 197(12):1677-87. [PubMed: 12796466] [MGI Ref ID J:116662]
Pelanda R; Schaal S; Torres RM; Rajewsky K. 1996. A prematurely expressed Ig kappa transgene, but not a V kappa J kappa gene segment targeted into the Ig kappa locus, can rescue B cell development in lambda 5-deficient mice. Immunity 5(3):229-239. [PubMed: 8808678] [MGI Ref ID J:35357]
Sonoda E; Pewzner-Jung Y; Schwers S; Taki S; Jung S; Eilat D; Rajewsky K. 1997. B cell development under the condition of allelic inclusion. Immunity 6(3):225-33. [PubMed: 9075923] [MGI Ref ID J:79556]
Yamagami T; ten Boekel E; Schaniel C; Andersson J; Rolink A; Melchers F. 1999. Four of five RAG-expressing JCkappa-/- small pre-BII cells have no L chain gene rearrangements: detection by high-efficiency single cell PCR. Immunity 11(3):309-16. [PubMed: 10514009] [MGI Ref ID J:57910]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.